The glucagon-like peptide-1 receptor (GLP-1R) market experienced significant growth in 2023, generating $37.2 billion in ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Structure Therapeutics Inc. has selected a lead oral small-molecule amylin receptor agonist, ACCG-2671, for the treatment of obesity. ACCG-2671 is a dual amylin and calcitonin receptor agonist (DACRA) ...

The functions of biomolecules, including lipids, nucleic acids and especially proteins are determined to a great extent by their structure. This structure–function relationship is a foundation ...

It is made of dead, flattened cells called keratinocytes that are shed approximately two weeks after they enter this layer. Keratinocytes produce keratin, a fibrous protein that helps provide ...